Biofrontera Inc. Increase (Decrease) in Due from Other Related Parties, Current
Biofrontera Inc. (BFRI) reported Increase (Decrease) in Due from Other Related Parties, Current of $54.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent · last filed 2026-08-13
- Biofrontera Inc. increase (decrease) in due from other related parties, current for the quarter ending 2026-06-30 was $55.00K.
- Biofrontera Inc. increase (decrease) in due from other related parties, current for the quarter ending 2026-03-31 was -$1.00K.
- Biofrontera Inc. increase (decrease) in due from other related parties, current for the quarter ending 2024-12-31 was $17.00K.
- Biofrontera Inc. increase (decrease) in due from other related parties, current for the quarter ending 2024-09-30 was -$16.00K.
- Biofrontera Inc. increase (decrease) in due from other related parties, current for fiscal 2024 was -$2.00K.
- Biofrontera Inc. increase (decrease) in due from other related parties, current for fiscal 2023 was -$6.47M.
- Biofrontera Inc. increase (decrease) in due from other related parties, current for fiscal 2022 was -$4.99M.
| Period end | Increase (Decrease) in Due from Other Related Parties, Current 3 month | Increase (Decrease) in Due from Other Related Parties, Current 6 month | Increase (Decrease) in Due from Other Related Parties, Current 9 month | Increase (Decrease) in Due from Other Related Parties, Current 12 month |
|---|---|---|---|---|
| 2026-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $54.00K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | -$1.00K 10-Q · filed 2026-05-14 | |||
| 2025-09-30 | -$68.00K 10-Q · filed 2025-11-12 | |||
| 2024-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $1.00K derived: sum of 2 quarters · filed 2026-03-19 | -$167.00K derived: sum of 3 quarters · filed 2026-03-19 | -$2.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$184.00K derived: sum of 2 quarters · filed 2025-11-12 | -$19.00K 10-Q · filed 2025-11-12 | -$2.84M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$3.00K 10-Q · filed 2025-08-13 | -$2.82M derived: sum of 3 quarters · filed 2025-08-13 | -$4.08M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $165.00K 10-Q · filed 2024-05-15 | -$2.65M derived: sum of 2 quarters · filed 2025-03-20 | -$3.91M derived: sum of 3 quarters · filed 2025-03-20 | -$3.58M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-12-31 | -$2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$4.07M derived: sum of 2 quarters · filed 2025-03-20 | -$3.75M derived: sum of 3 quarters · filed 2025-03-20 | -$6.47M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$932.00K derived: sum of 2 quarters · filed 2024-11-14 | -$3.65M 10-Q · filed 2024-11-14 | -$3.50M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $323.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$2.40M 10-Q · filed 2024-08-14 | -$2.24M derived: sum of 3 quarters · filed 2024-08-14 | -$1.78M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$2.72M 10-Q · filed 2024-05-15 | -$2.56M derived: sum of 2 quarters · filed 2024-05-15 | -$2.11M derived: sum of 3 quarters · filed 2024-05-15 | -$7.75M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $612.00K derived: sum of 2 quarters · filed 2024-03-15 | -$5.03M derived: sum of 3 quarters · filed 2024-03-15 | -$4.99M 10-K · filed 2024-03-15 |
| 2022-09-30 | $457.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$5.18M derived: sum of 2 quarters · filed 2023-11-09 | -$5.14M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$5.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$5.60M 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $38.00K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $11.39M 8-K · filed 2023-10-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |